Michele Wozniak

Michele Wozniak is a seasoned professional in the fields of precision medicine and oncology biomarkers, currently serving as Director at Astellas Pharma since October 2017, with previous roles including Associate Director and Director in the same domain. Prior experience includes serving as Principal Scientist and Senior Scientist at Abbott Molecular from September 2013 to October 2017, focusing on real-time PCR assay development and companion diagnostics. Michele holds a Bachelor of Science in Biology from Purdue University, a Ph.D. in Cell/Cellular and Molecular Biology from the University of Wisconsin-Madison, and has completed postdoctoral studies at both the University of Pennsylvania and The Johns Hopkins University School of Medicine, specializing in Bioengineering and Biomedical Engineering as well as Cellular and Molecular Biology.